Share Price and Basic Stock Data
Last Updated: November 28, 2025, 11:03 am
| PEG Ratio | 2.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
EMS Ltd operates in the water supply and management industry, showcasing a robust business model with significant revenue growth. For the fiscal year ending March 2025, the company reported sales of ₹966 Cr, up from ₹793 Cr in March 2024, marking a year-on-year increase of 21.8%. This growth trajectory is reflected in the quarterly sales figures, where the most recent quarter (September 2023) recorded sales of ₹211 Cr, a notable increase from ₹190 Cr in March 2023. The company’s revenue growth is underscored by a strong operating profit margin (OPM) of 26%, suggesting effective cost management amid rising sales. The operating profit for March 2025 stood at ₹254 Cr, up from ₹204 Cr in the previous year. With a trailing twelve months (TTM) sales figure of ₹987 Cr, EMS Ltd is well-positioned within its sector, benefitting from increasing demand for water management solutions in India.
Profitability and Efficiency Metrics
EMS Ltd has demonstrated impressive profitability metrics, with a net profit of ₹184 Cr for the fiscal year ending March 2025, an increase from ₹153 Cr the previous year, translating to a net profit margin of 19.02%. The operating profit margin has remained stable, reflecting the company’s ability to maintain efficiency despite fluctuating sales. The interest coverage ratio (ICR) stood at an impressive 31.66x, indicating that the company can comfortably meet its interest obligations, which is crucial for financial stability. Furthermore, the return on equity (ROE) was reported at 20.7%, highlighting effective utilization of shareholders’ funds. However, the cash conversion cycle (CCC) has risen to 142 days, indicating a potential area for improvement in working capital management. Overall, EMS Ltd’s profitability metrics suggest a strong operational performance, although the increasing CCC may pose challenges in liquidity management.
Balance Sheet Strength and Financial Ratios
EMS Ltd’s balance sheet appears robust, with no reported borrowings, indicating a debt-free status that is a significant strength in the current economic environment. The company’s market capitalization is ₹2,552 Cr, with a price-to-earnings (P/E) ratio of 15.6, which is competitive compared to industry averages. The price-to-book value (P/BV) ratio of 3.52x suggests that the stock is priced at a premium relative to its book value of ₹175.70 per share. The current ratio is notably high at 8.15x, indicating strong liquidity, which allows EMS Ltd to cover its short-term liabilities comfortably. However, the rising cash conversion cycle could imply longer periods of capital tie-up, potentially affecting cash flow. The return on capital employed (ROCE) stood at 27%, reflecting efficient capital utilization, but a slight decline from the previous year’s 29% suggests the need for vigilant operational management moving forward.
Shareholding Pattern and Investor Confidence
The shareholding pattern of EMS Ltd indicates a strong promoter holding at 69.70%, reflecting significant management confidence in the company’s prospects. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold a minor stake of 0.15% and 0.35%, respectively, which may suggest limited institutional interest. The public shareholding has increased to 29.79%, with the number of shareholders rising to 1,28,706 as of September 2025, demonstrating growing retail investor interest. This increasing public participation can enhance liquidity in the stock, providing a more dynamic trading environment. However, the dwindling institutional ownership, particularly among FIIs, may raise questions about broader market sentiment towards the stock. Overall, the stable promoter holding coupled with increasing public participation suggests a solid foundation of investor confidence, although the low institutional presence could be a concern for future capital inflows.
Outlook, Risks, and Final Insight
Looking ahead, EMS Ltd is positioned to capitalize on the growing demand for water management solutions, particularly in light of increasing urbanization and environmental concerns. However, risks include potential regulatory changes in the water sector and competition from emerging players that could pressure margins. The rising cash conversion cycle could also impact liquidity if not addressed. Should EMS Ltd effectively manage its operational efficiencies and navigate regulatory landscapes, it could enhance its profitability and sustain growth. Conversely, failure to address these risks could hinder its performance. The company’s strong financial health, characterized by no debt and solid liquidity ratios, provides a buffer against economic fluctuations. In conclusion, while EMS Ltd shows promise, its ability to adapt to market challenges will be crucial for maintaining its growth trajectory and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of EMS Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| EMS Ltd | 2,429 Cr. | 437 | 1,017/429 | 14.9 | 187 | 0.34 % | 26.9 % | 20.7 % | 10.0 |
| Industry Average | 2,429.00 Cr | 437.00 | 14.90 | 187.00 | 0.34% | 26.90% | 20.70% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121 | 151 | 190 | 138 | 211 | 200 | 245 | 206 | 233 | 245 | 270 | 239 |
| Expenses | 78 | 109 | 143 | 106 | 154 | 153 | 178 | 156 | 165 | 174 | 205 | 185 |
| Operating Profit | 43 | 43 | 48 | 32 | 57 | 47 | 68 | 50 | 69 | 71 | 65 | 54 |
| OPM % | 36% | 28% | 25% | 23% | 27% | 23% | 28% | 24% | 29% | 29% | 24% | 23% |
| Other Income | 2 | 1 | 2 | 1 | 8 | 6 | 1 | 2 | 2 | 3 | 2 | 2 |
| Interest | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 3 | 3 | 3 |
| Profit before tax | 43 | 42 | 48 | 31 | 62 | 51 | 64 | 49 | 67 | 70 | 63 | 51 |
| Tax % | 31% | 28% | 25% | 25% | 26% | 26% | 26% | 25% | 26% | 27% | 25% | 25% |
| Net Profit | 30 | 30 | 36 | 23 | 45 | 37 | 47 | 37 | 50 | 51 | 47 | 38 |
| EPS in Rs | 8.15 | 6.72 | 8.53 | 6.68 | 8.94 | 9.09 | 8.39 | 6.82 |
Last Updated: August 19, 2025, 3:47 pm
Below is a detailed analysis of the quarterly data for EMS Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 239.00 Cr.. The value appears to be declining and may need further review. It has decreased from 270.00 Cr. (Mar 2025) to 239.00 Cr., marking a decrease of 31.00 Cr..
- For Expenses, as of Jun 2025, the value is 185.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 205.00 Cr. (Mar 2025) to 185.00 Cr., marking a decrease of 20.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 65.00 Cr. (Mar 2025) to 54.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Jun 2025, the value is 23.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Mar 2025) to 23.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 12.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
- For Net Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 9.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 6.82. The value appears to be declining and may need further review. It has decreased from 8.39 (Mar 2025) to 6.82, marking a decrease of 1.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:25 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 326 | 331 | 360 | 538 | 793 | 966 | 987 |
| Expenses | 230 | 232 | 247 | 388 | 589 | 712 | 729 |
| Operating Profit | 96 | 99 | 113 | 150 | 204 | 254 | 259 |
| OPM % | 30% | 30% | 31% | 28% | 26% | 26% | 26% |
| Other Income | 7 | 5 | 3 | 5 | 16 | 16 | 9 |
| Interest | 3 | 4 | 6 | 4 | 6 | 11 | 7 |
| Depreciation | 2 | 2 | 3 | 3 | 7 | 10 | 10 |
| Profit before tax | 98 | 98 | 107 | 148 | 207 | 249 | 251 |
| Tax % | 26% | 27% | 27% | 26% | 26% | 26% | |
| Net Profit | 72 | 72 | 79 | 109 | 153 | 184 | 185 |
| EPS in Rs | 27.44 | 33.05 | 33.24 | ||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 7% | 5% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 9.72% | 37.97% | 40.37% | 20.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | 9.72% | 28.25% | 2.39% | -20.11% |
EMS Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
Last Updated: September 5, 2025, 3:21 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 44 | 103 | 160 | 84 | 112 | 142 |
| Inventory Days | ||||||
| Days Payable | ||||||
| Cash Conversion Cycle | 44 | 103 | 160 | 84 | 112 | 142 |
| Working Capital Days | 125 | 183 | 219 | 137 | 180 | 187 |
| ROCE % | 37% | 33% | 33% | 29% | 27% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Navi Flexi Cap Fund | 106,000 | 2.27 | 5.76 | 30,000 | 2025-10-17 02:28:48 | 253.33% |
| Navi Aggressive Hybrid Fund | 56,737 | 2.51 | 3.08 | 21,500 | 2025-10-17 02:53:24 | 163.89% |
| Navi Large & Midcap Fund | 10,500 | 0.18 | 0.57 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 33.05 | 29.38 | 23.16 | 67.27 | 61.24 |
| Diluted EPS (Rs.) | 33.05 | 29.38 | 23.16 | 67.27 | 61.24 |
| Cash EPS (Rs.) | 34.83 | 28.67 | 23.88 | 69.32 | 62.68 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 175.70 | 144.16 | 104.86 | 324.36 | 257.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 175.70 | 144.16 | 104.86 | 324.36 | 257.09 |
| Revenue From Operations / Share (Rs.) | 173.93 | 142.86 | 114.50 | 306.26 | 281.45 |
| PBDIT / Share (Rs.) | 48.09 | 39.55 | 33.00 | 98.52 | 88.83 |
| PBIT / Share (Rs.) | 46.35 | 38.37 | 32.28 | 96.37 | 87.36 |
| PBT / Share (Rs.) | 44.84 | 37.24 | 31.46 | 91.48 | 83.57 |
| Net Profit / Share (Rs.) | 33.09 | 27.49 | 23.16 | 67.17 | 61.20 |
| NP After MI And SOA / Share (Rs.) | 33.05 | 27.44 | 22.91 | 66.51 | 61.18 |
| PBDIT Margin (%) | 27.64 | 27.68 | 28.82 | 32.16 | 31.56 |
| PBIT Margin (%) | 26.65 | 26.85 | 28.19 | 31.46 | 31.03 |
| PBT Margin (%) | 25.77 | 26.06 | 27.47 | 29.87 | 29.69 |
| Net Profit Margin (%) | 19.02 | 19.24 | 20.22 | 21.93 | 21.74 |
| NP After MI And SOA Margin (%) | 19.00 | 19.20 | 20.01 | 21.71 | 21.73 |
| Return on Networth / Equity (%) | 18.81 | 19.09 | 21.94 | 20.55 | 23.80 |
| Return on Capital Employeed (%) | 23.98 | 24.18 | 26.92 | 28.74 | 32.87 |
| Return On Assets (%) | 15.75 | 15.70 | 16.78 | 15.55 | 19.00 |
| Long Term Debt / Equity (X) | 0.08 | 0.08 | 0.09 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.08 | 0.08 | 0.09 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.90 | 0.98 | 0.94 | 0.00 | 0.90 |
| Current Ratio (X) | 8.15 | 6.14 | 5.41 | 3.82 | 4.54 |
| Quick Ratio (X) | 7.63 | 5.14 | 4.06 | 3.32 | 4.00 |
| Inventory Turnover Ratio (X) | 9.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 3.64 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 3.49 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 96.36 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 96.51 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 31.66 | 34.95 | 40.38 | 20.15 | 23.44 |
| Interest Coverage Ratio (Post Tax) (X) | 22.79 | 25.29 | 29.34 | 14.74 | 17.15 |
| Enterprise Value (Cr.) | 3358.69 | 2183.92 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 3.48 | 2.75 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 12.58 | 9.94 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 3.55 | 2.81 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 0.00 | 96.35 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.52 | 2.79 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 3.55 | 2.81 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.05 | 0.06 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for EMS Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 29.38 (Mar 24) to 33.05, marking an increase of 3.67.
- For Diluted EPS (Rs.), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 29.38 (Mar 24) to 33.05, marking an increase of 3.67.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.83. This value is within the healthy range. It has increased from 28.67 (Mar 24) to 34.83, marking an increase of 6.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 175.70. It has increased from 144.16 (Mar 24) to 175.70, marking an increase of 31.54.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 175.70. It has increased from 144.16 (Mar 24) to 175.70, marking an increase of 31.54.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.93. It has increased from 142.86 (Mar 24) to 173.93, marking an increase of 31.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 48.09. This value is within the healthy range. It has increased from 39.55 (Mar 24) to 48.09, marking an increase of 8.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 46.35. This value is within the healthy range. It has increased from 38.37 (Mar 24) to 46.35, marking an increase of 7.98.
- For PBT / Share (Rs.), as of Mar 25, the value is 44.84. This value is within the healthy range. It has increased from 37.24 (Mar 24) to 44.84, marking an increase of 7.60.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 33.09. This value is within the healthy range. It has increased from 27.49 (Mar 24) to 33.09, marking an increase of 5.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 27.44 (Mar 24) to 33.05, marking an increase of 5.61.
- For PBDIT Margin (%), as of Mar 25, the value is 27.64. This value is within the healthy range. It has decreased from 27.68 (Mar 24) to 27.64, marking a decrease of 0.04.
- For PBIT Margin (%), as of Mar 25, the value is 26.65. This value exceeds the healthy maximum of 20. It has decreased from 26.85 (Mar 24) to 26.65, marking a decrease of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 25.77. This value is within the healthy range. It has decreased from 26.06 (Mar 24) to 25.77, marking a decrease of 0.29.
- For Net Profit Margin (%), as of Mar 25, the value is 19.02. This value exceeds the healthy maximum of 10. It has decreased from 19.24 (Mar 24) to 19.02, marking a decrease of 0.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.00. This value is within the healthy range. It has decreased from 19.20 (Mar 24) to 19.00, marking a decrease of 0.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.81. This value is within the healthy range. It has decreased from 19.09 (Mar 24) to 18.81, marking a decrease of 0.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.98. This value is within the healthy range. It has decreased from 24.18 (Mar 24) to 23.98, marking a decrease of 0.20.
- For Return On Assets (%), as of Mar 25, the value is 15.75. This value is within the healthy range. It has increased from 15.70 (Mar 24) to 15.75, marking an increase of 0.05.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.98 (Mar 24) to 0.90, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 8.15. This value exceeds the healthy maximum of 3. It has increased from 6.14 (Mar 24) to 8.15, marking an increase of 2.01.
- For Quick Ratio (X), as of Mar 25, the value is 7.63. This value exceeds the healthy maximum of 2. It has increased from 5.14 (Mar 24) to 7.63, marking an increase of 2.49.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.08. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 9.08, marking an increase of 9.08.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.64 (Mar 24) to 0.00, marking a decrease of 3.64.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.49 (Mar 24) to 0.00, marking a decrease of 3.49.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.36 (Mar 24) to 0.00, marking a decrease of 96.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.51 (Mar 24) to 0.00, marking a decrease of 96.51.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 31.66. This value is within the healthy range. It has decreased from 34.95 (Mar 24) to 31.66, marking a decrease of 3.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.79. This value is within the healthy range. It has decreased from 25.29 (Mar 24) to 22.79, marking a decrease of 2.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,358.69. It has increased from 2,183.92 (Mar 24) to 3,358.69, marking an increase of 1,174.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 2.75 (Mar 24) to 3.48, marking an increase of 0.73.
- For EV / EBITDA (X), as of Mar 25, the value is 12.58. This value is within the healthy range. It has increased from 9.94 (Mar 24) to 12.58, marking an increase of 2.64.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.55. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.55, marking an increase of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.35 (Mar 24) to 0.00, marking a decrease of 96.35.
- For Price / BV (X), as of Mar 25, the value is 3.52. This value exceeds the healthy maximum of 3. It has increased from 2.79 (Mar 24) to 3.52, marking an increase of 0.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.55. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.55, marking an increase of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in EMS Ltd:
- Net Profit Margin: 19.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.98% (Industry Average ROCE: 26.9%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.81% (Industry Average ROE: 20.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 22.79
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 7.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.9 (Industry average Stock P/E: 14.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Water Supply & Management | 701, DLF Tower A, New Delhi Delhi 110025 | cs@ems.co.in http://www.ems.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramveer Singh | Chairman & Director |
| Mr. Ashish Tomar | Managing Director & CFO |
| Mrs. Kritika Tomar | Whole Time Director |
| Ms. Swati Jain | Ind. Non-Executive Director |
| Mr. Mukesh Garg | Ind. Non-Executive Director |
| Mrs. Chetna | Ind. Non-Executive Director |
| Mr. Achal Kapoor | Ind. Non-Executive Director |